Chris Hagan on Celgene and Bristol-Meyers Merger| NECN Market Analysis

Celgene Gains 20%, Bristol-Myers Down 13% on Merger News

Chris Hagan, vice president at Adviser Investments, has the market analysis for Thursday, January 3. Nine of the S&P 500’s 11 sectors finished lower today, with technology stocks down about 5%. Airline stocks also fell; Delta Air Lines led those declines at 9% and American Airlines close behind, down 8%. Meanwhile, the biotechnology sector saw gains following the $74 billion Bristol-Myers Squibb-Celgene merger announcement. Celgene’s stock gained more than 20%, while Bristol-Myers Squibb fell 13% on the news.

Recent Videos

View All Videos

Adam Johnson Sees the Sunny Side of Stocks’ Slide

Adam Johnson on Cheddar: An Opportunistic View of the Sell-Off

Inflation, Health Tech, And Alcoa’s Strong Q4

Lowell on Fox Business: Traders Looking Beyond Omicron, Inflation

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.